Cargando…
MicroRNA-138 inhibits tumor growth and enhances chemosensitivity in human cervical cancer by targeting H2AX
MicroRNA-138 (miR-138) acts as a key regulator in the modulation of carcinogenesis in numerous tumor types. Chemoresistance is common and relevant to the failure of multiple treatment strategies for cervical cancer. However, the biological role of miR-138 in the progression and chemosensitivity of c...
Autores principales: | Yuan, Min, Zhao, Shuting, Chen, Rui, Wang, Guozeng, Bie, Yachun, Wu, Qianyu, Cheng, Jingxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909785/ https://www.ncbi.nlm.nih.gov/pubmed/31853324 http://dx.doi.org/10.3892/etm.2019.8238 |
Ejemplares similares
-
DNA methylation of miR-138 regulates cell proliferation and EMT in cervical cancer by targeting EZH2
por: Chen, Rui, et al.
Publicado: (2022) -
MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer
por: Shen, Hua, et al.
Publicado: (2016) -
MicroRNA-3196 is inhibited by H2AX phosphorylation and attenuates lung cancer cell apoptosis by downregulating PUMA
por: Xu, Chengshan, et al.
Publicado: (2016) -
Chronic oxidative stress promotes H2AX protein degradation and enhances chemosensitivity in breast cancer patients
por: Gruosso, Tina, et al.
Publicado: (2016) -
MicroRNA-138 Suppresses Neutrophil Gelatinase-Associated Lipocalin Expression and Inhibits Tumorigenicity
por: Lee, Ying Chu, et al.
Publicado: (2012)